Table 5 The genotype distribution of 5-HTTLPR and rs25531 gene polymorphism between TN patients stratified by treatment response
Genotype | Treatment without improvement | Treatment with improvement | Adjusted OR | 95% CI | Adjusted P | ||||
|---|---|---|---|---|---|---|---|---|---|
5-HTTLPR | Long-long | 15 | 19.74% | 46 | 32.62% | 1.000 | |||
Long-short | 39 | 51.32% | 72 | 51.06% | 1.661 | 0.824 | 3.349 | 0.154 | |
Short-short | 22 | 28.95% | 23 | 16.31% | 2.933 | 1.285 | 6.696 | 0.009 | |
Long | 69 | 45.39% | 164 | 58.16% | 1.000 | ||||
short | 83 | 54.61% | 118 | 41.84% | 1.672 | 1.124 | 2.488 | 0.011 | |
rs25531 | AA | 13 | 17.11% | 31 | 21.99% | 1.000 | |||
AG | 45 | 59.21% | 76 | 53.90% | 1.412 | 0.670 | 2.975 | 0.363 | |
GG | 18 | 23.68% | 34 | 24.11% | 1.262 | 0.532 | 2.994 | 0.597 | |
A | 71 | 46.71% | 138 | 48.94% | 1.000 | ||||
G | 81 | 53.29% | 144 | 51.06% | 1.093 | 0.737 | 1.623 | 0.851 | |